Privacy is not a compliance checkbox. In Clinical Research, It's the Foundation of Trust.  Clinical development runs on the most sensitive information a person will ever share: their diagnoses, their genetics, their lab values, the free-text notes a clinician wrote about them on a difficult day. When a patient consents to a trial, they are extending trust — to the sponsor, to the site, and to every system and partner that will touch their data along the way. Protecting that trust is not a legal formality. It is the license to operate. That is why security and privacy cannot be something bolted on at the end, in the weeks before a submission or an audit. They have to be designed into how data is collected, moved, analyzed and stored — from the first case report form to the final clinical study report. A layered regulatory landscape For programs serving US patients and sponsors, several frameworks operate at once, and they overlap rather than replace one another: → HIPAA governs...